Literature DB >> 24628418

Thioredoxin-interacting protein stimulates its own expression via a positive feedback loop.

Junqin Chen1, Gu Jing, Guanlan Xu, Anath Shalev.   

Abstract

Thioredoxin-interacting protein (TXNIP) has emerged as a key regulator of important cellular processes including redox state, inflammation, and apoptosis and plays a particularly critical role in pancreatic β-cell biology and diabetes development. High glucose and diabetes induce TXNIP expression, whereas inhibition of TXNIP expression or TXNIP deficiency protects against pancreatic β-cell apoptosis and diabetes. We now have discovered that TXNIP stimulates its own expression by promoting dephosphorylation and nuclear translocation of its transcription factor, carbohydrate response element-binding protein (ChREBP), resulting in a positive feedback loop as well as regulation of other ChREBP target genes playing important roles in glucose and lipid metabolism. Considering the detrimental effects of elevated TXNIP in β-cell biology, this novel pathway sheds new light onto the vicious cycle of increased TXNIP, leading to even more TXNIP expression, oxidative stress, inflammation, β-cell apoptosis, and diabetes progression. Moreover, the results demonstrate, for the first time, that TXNIP modulates ChREBP activity and thereby uncover a previously unappreciated link between TXNIP signaling and cell metabolism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24628418      PMCID: PMC4004782          DOI: 10.1210/me.2014-1041

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  35 in total

1.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation.

Authors:  Rongbin Zhou; Aubry Tardivel; Bernard Thorens; Inpyo Choi; Jürg Tschopp
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

2.  Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression.

Authors:  Carrie A Stoltzman; Christopher W Peterson; Kevin T Breen; Deborah M Muoio; Andrew N Billin; Donald E Ayer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

3.  Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein.

Authors:  Geetu Saxena; Junqin Chen; Anath Shalev
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

4.  ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.

Authors:  Pierre-Damien Denechaud; Pascale Bossard; Jean-Marc A Lobaccaro; Lesley Millatt; Bart Staels; Jean Girard; Catherine Postic
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

5.  Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity.

Authors:  Michael N Davies; Brennon L O'Callaghan; Howard C Towle
Journal:  J Biol Chem       Date:  2008-06-30       Impact factor: 5.157

6.  Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells.

Authors:  Hyunjoo Cha-Molstad; Geetu Saxena; Junqin Chen; Anath Shalev
Journal:  J Biol Chem       Date:  2009-05-01       Impact factor: 5.157

7.  Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes.

Authors:  Junqin Chen; Simon T Hui; Francesca M Couto; Imran N Mungrue; Dawn B Davis; Alan D Attie; Aldons J Lusis; Roger A Davis; Anath Shalev
Journal:  FASEB J       Date:  2008-06-13       Impact factor: 5.191

8.  Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein.

Authors:  Junqin Chen; Hyunjoo Cha-Molstad; Anna Szabo; Anath Shalev
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-03-03       Impact factor: 4.310

9.  Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death.

Authors:  Junqin Chen; Ghislaine Fontes; Geetu Saxena; Vincent Poitout; Anath Shalev
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

10.  TXNIP regulates peripheral glucose metabolism in humans.

Authors:  Hemang Parikh; Emma Carlsson; William A Chutkow; Lovisa E Johansson; Heidi Storgaard; Pernille Poulsen; Richa Saxena; Christine Ladd; P Christian Schulze; Michael J Mazzini; Christine Bjørn Jensen; Anna Krook; Marie Björnholm; Hans Tornqvist; Juleen R Zierath; Martin Ridderstråle; David Altshuler; Richard T Lee; Allan Vaag; Leif C Groop; Vamsi K Mootha
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

View more
  16 in total

1.  Type 2 diabetes and leucocyte DNA methylation: an epigenome-wide association study in over 1,500 older adults.

Authors:  Ines Florath; Katja Butterbach; Jonathan Heiss; Melanie Bewerunge-Hudler; Yan Zhang; Ben Schöttker; Hermann Brenner
Journal:  Diabetologia       Date:  2015-10-03       Impact factor: 10.122

Review 2.  Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.

Authors:  Lance Thielen; Anath Shalev
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-04       Impact factor: 3.243

Review 3.  Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic β-cell.

Authors:  Anath Shalev
Journal:  Mol Endocrinol       Date:  2014-06-09

4.  Deletion of thioredoxin interacting protein (TXNIP) augments hyperoxia-induced vaso-obliteration in a mouse model of oxygen induced-retinopathy.

Authors:  Mohammed A Abdelsaid; Suraporn Matragoon; Adviye Ergul; Azza B El-Remessy
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

5.  Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway.

Authors:  Chunling Huang; Yuan Zhang; Darren J Kelly; Christina Y R Tan; Anthony Gill; Delfine Cheng; Filip Braet; Jin-Sung Park; Carolyn M Sue; Carol A Pollock; Xin-Ming Chen
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

6.  Induction of the ChREBPβ Isoform Is Essential for Glucose-Stimulated β-Cell Proliferation.

Authors:  Pili Zhang; Anil Kumar; Liora S Katz; Lucy Li; Martine Paulynice; Mark A Herman; Donald K Scott
Journal:  Diabetes       Date:  2015-09-17       Impact factor: 9.461

7.  Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic β-cells.

Authors:  Yan Luo; Fengli He; Li Hu; Luo Hai; Meifeng Huang; Zhipeng Xu; Jingjing Zhang; Zhiguang Zhou; Feng Liu; Yan-Shan Dai
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

Review 8.  Adipose tissue macrophages: going off track during obesity.

Authors:  Lily Boutens; Rinke Stienstra
Journal:  Diabetologia       Date:  2016-03-03       Impact factor: 10.122

9.  KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways.

Authors:  Chunling Huang; Mike Z Lin; Delfine Cheng; Filip Braet; Carol A Pollock; Xin-Ming Chen
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

10.  New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats.

Authors:  Chunchun Ding; Yan Zhao; Xue Shi; Ning Zhang; Guo Zu; Zhenlu Li; Junjun Zhou; Dongyan Gao; Li Lv; Xiaofeng Tian; Jihong Yao
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.